Experienced in Synovial Sarcoma

Dr. William C. Dooley

Surgical Oncology | General Surgery
825 Ne 10th St, Oupb5200, 
Oklahoma City, OK 
Accepting New Patients
Experienced in Synovial Sarcoma
825 Ne 10th St, Oupb5200, 
Oklahoma City, OK 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

William Dooley is a Surgical Oncologist and a General Surgeon in Oklahoma City, Oklahoma. Dr. Dooley is rated as an Experienced provider by MediFind in the treatment of Synovial Sarcoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Mastectomy. Dr. Dooley is currently accepting new patients.

His clinical research consists of co-authoring 31 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Surgical Oncology
General Surgery
Licenses
Surgery in OK
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

825 Ne 10th St, Oupb5200, Oklahoma City, OK 73104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention Versus Placebo Control in Premenopausal Women
Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention Versus Placebo Control in Premenopausal Women
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Other, Drug
Study Drug: Metformin Hydrochloride
Study Phase: Phase 3
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx® System® at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx® System® at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 31, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
ARM: Axillary Reverse Mapping - a Prospective Trial to Study Rates of Lymphedema and Regional Recurrence After Sentinel Lymph Node Biopsy and Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Dissection with and Without Axillary Reverse Mapping
ARM: Axillary Reverse Mapping - a Prospective Trial to Study Rates of Lymphedema and Regional Recurrence After Sentinel Lymph Node Biopsy and Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Dissection with and Without Axillary Reverse Mapping
Enrollment Status: Active_not_recruiting
Publish Date: January 17, 2025
Intervention Type: Other, Drug, Procedure
Study Drug: Isosulfan Blue
Study Phase: Phase 3
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: a Phase III Study
Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: a Phase III Study
Enrollment Status: Active_not_recruiting
Publish Date: January 10, 2025
Intervention Type: Drug
Study Drugs: Fulvestrant, Anastrozole
Study Phase: Phase 3
Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry
Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry
Enrollment Status: Completed
Publish Date: June 27, 2018
View 5 Less Clinical Trials

31 Total Publications

Surgical Delay-Associated Mortality Risk Varies by Subtype in Loco-Regional Breast Cancer Patients in SEER-Medicare.
Surgical Delay-Associated Mortality Risk Varies by Subtype in Loco-Regional Breast Cancer Patients in SEER-Medicare.
Journal: Research square
Published: April 25, 2024
Similar Doctors
Advanced in Synovial Sarcoma
Dr. Jeremy White
Orthopedics | Surgical Oncology
Advanced in Synovial Sarcoma
Dr. Jeremy White
Orthopedics | Surgical Oncology

Ou Health Partners Inc

800 Ne 10th St, Ouhp Stephenson Cancer C, 
Oklahoma City, OK 
 (0.1 miles away)
405-271-4088
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jeremy White is an Orthopedics specialist and a Surgical Oncologist in Oklahoma City, Oklahoma. Dr. White is rated as a Distinguished provider by MediFind in the treatment of Synovial Sarcoma. His top areas of expertise are Infantile Myofibromatosis, Congenital Generalized Fibromatosis, Rhabdomyosarcoma Embryonal, Knee Replacement, and Hip Replacement.

Experienced in Synovial Sarcoma
Dr. Ajay K. Jain
General Surgery | Surgical Oncology
Experienced in Synovial Sarcoma
Dr. Ajay K. Jain
General Surgery | Surgical Oncology

Ou Health Partners Inc

1122 Ne 13th St, 
Oklahoma City, OK 
 (0.5 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ajay Jain is a General Surgeon and a Surgical Oncologist in Oklahoma City, Oklahoma. Dr. Jain is rated as a Distinguished provider by MediFind in the treatment of Synovial Sarcoma. His top areas of expertise are Progressive Familial Intrahepatic Cholestasis Type 3, Familial Pancreatic Cancer, Progressive Familial Intrahepatic Cholestasis Type 1, Percutaneous Coronary Intervention (PCI), and Angioplasty. Dr. Jain is currently accepting new patients.

Experienced in Synovial Sarcoma
Dr. William C. Mustain
Colorectal Surgery | General Surgery
Experienced in Synovial Sarcoma
Dr. William C. Mustain
Colorectal Surgery | General Surgery

Mercy Clinic Oklahoma Communities

4205 Mcauley Blvd, Suite 375, 
Oklahoma City, OK 
 (10.6 miles away)
405-751-4343
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Mustain is a Colorectal Surgeon and a General Surgeon in Oklahoma City, Oklahoma. Dr. Mustain is rated as a Distinguished provider by MediFind in the treatment of Synovial Sarcoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Bladder Reconstruction, and Hernia Surgery. Dr. Mustain is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dooley's expertise for a condition
ConditionClose
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile